BMRN
Biomarin Pharmaceutical Inc
Price:  
65.97 
USD
Volume:  
802,558.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin WACC - Weighted Average Cost of Capital

The WACC of Biomarin Pharmaceutical Inc (BMRN) is 7.5%.

The Cost of Equity of Biomarin Pharmaceutical Inc (BMRN) is 7.85%.
The Cost of Debt of Biomarin Pharmaceutical Inc (BMRN) is 4.25%.

Range Selected
Cost of equity 6.90% - 8.80% 7.85%
Tax rate 10.60% - 36.60% 23.60%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.6% - 8.3% 7.5%
WACC

Biomarin WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 8.80%
Tax rate 10.60% 36.60%
Debt/Equity ratio 0.09 0.09
Cost of debt 4.00% 4.50%
After-tax WACC 6.6% 8.3%
Selected WACC 7.5%